To determine whether the suppression effect of fluphenazine on the development of HCC depends on the activation of KLF14 in vivo, we performed a mouse xenograft model via the subcutaneous injection of control or KLF14-silenced HepG2 cells in nude mice (Fig. 9G). This evidence concerns the gene KLF14 and hepatocellular carcinoma.